Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy

Shankland, 1999, Cell cycle regulatory proteins in glomerular disease, Kidney Int, 56, 1208, 10.1046/j.1523-1755.1999.00709.x Shankland, 2000, Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis, Am J Physiol Renal Physiol, 278, F515, 10.1152/ajprenal.2000.278.4.F515 Shankland, 1996, Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis, Kidney Int, 50, 1230, 10.1038/ki.1996.432 Terada, 1998, Cyclins and the cyclin-kinase system—their potential roles in nephrology, Nephrol Dial Transplant, 13, 1913, 10.1093/ndt/13.8.1913 Schocklmann, 1999, Regulation of mesangial cell proliferation, Kidney Int, 56, 1199, 10.1046/j.1523-1755.1999.00710.x Pippin, 1997, Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist, J Clin Invest, 100, 2512, 10.1172/JCI119793 Shankland, 1997, Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo, Kidney Int, 52, 404, 10.1038/ki.1997.347 Schoecklmann, 1997, TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation, Kidney Int, 51, 1228, 10.1038/ki.1997.168 Shankland, 1997, Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1, Kidney Int, 51, 1088, 10.1038/ki.1997.151 Shankland, 1994, Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy, Kidney Int, 46, 430, 10.1038/ki.1994.291 Berger, 1969, IgA glomerular deposits in renal disease, Transplant Proc, 1, 939 Ibels, 1994, IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature, Medicine (Baltimore), 73, 79, 10.1097/00005792-199403000-00002 Radford, 1997, Predicting renal outcome in IgA nephropathy, J Am Soc Nephrol, 8, 199, 10.1681/ASN.V82199 Sinniah, 1981, The pathology of mesangial IgA nephritis with clinical correlation, Histopathology, 5, 469, 10.1111/j.1365-2559.1981.tb01811.x Sinniah, 1976, Glomerular lesions in asymptomatic microscopic hematuria discovered on routine medical examination, Clin Nephrol, 5, 216 Qiu, 2004, Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy, J Am Soc Nephrol, 15, 79, 10.1097/01.ASN.0000104573.54132.2E Rui-Mei, 1998, In situ analysis of adhesion molecule expression in kidneys infected with murine malaria, J Pathol, 185, 219, 10.1002/(SICI)1096-9896(199806)185:2<219::AID-PATH77>3.0.CO;2-Q Khan, 1993, Renal tubular antiproteinase (alpha-1-antitrypsin and alpha-1-antichymotrypsin) response in tubulo-interstitial damage, Nephron, 65, 232, 10.1159/000187480 Sinniah, 1983, Effect of IgA deposits on the glomerular mesangium in Berger's disease, Ultrastruct Pathol, 4, 9, 10.3109/01913128309140568 To, 2000, Outcome of IgA nephropathy in adults graded by chronic histological lesions, Am J Kidney Dis, 35, 392, 10.1016/S0272-6386(00)70191-0 Soma, 1995, Participation of CR1 (CD35), CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in membranoproliferative glomerulonephritis type I, Clin Exp Immunol, 100, 269, 10.1111/j.1365-2249.1995.tb03664.x Hotta, 2002, Regression of IgA nephropathy: a repeat biopsy study, Am J Kidney Dis, 39, 493, 10.1053/ajkd.2002.31399 Nakopoulou, 1997, The value of proliferating cell nuclear antigen (PCNA)/cyclin in the assessment of cell proliferation in glomerulonephritis, Histol Histopathol, 12, 655 Yoshioka, 1987, Cellular and non-cellular compositions of crescents in human glomerulonephritis, Kidney Int, 32, 284, 10.1038/ki.1987.205 Nagata, 2002, Role of cell cycle molecules in the pathophysiology of glomerular epithelial cells, Microsc Res Techn, 57, 203, 10.1002/jemt.10074 Mundle, 2003, Evolving intricacies and implications of E2F1 regulation, FASEB J, 17, 569, 10.1096/fj.02-0431rev Inoshita, 1999, Regulation of the G1/S transition phase in mesangial cells by E2F1, Kidney Int, 56, 1238, 10.1046/j.1523-1755.1999.00705.x Ren, 2002, E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints, Genes Dev, 16, 245, 10.1101/gad.949802 Muller, 2001, E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis, Genes Dev, 15, 267, 10.1101/gad.864201 Inoshita, 1999, Roles of E2F1 in mesangial cell proliferation in vitro, Kidney Int, 56, 2085, 10.1046/j.1523-1755.1999.00799.x Maeshima, 1998, Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro in vivo, J Clin Invest, 101, 2589, 10.1172/JCI429 Tomita, 1998, An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro, Am J Physiol, 275, F278 Tsuboi, 2000, Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells, Kidney Int, 57, 1581, 10.1046/j.1523-1755.2000.00002.x Fujigaki, 2001, Cytokines and cell cycle regulation in the fibrous progression of crescent formation in antiglomerular basement membrane nephritis of WKY rats, Virchows Arch, 439, 35, 10.1007/s004280100433 Pabst, 1983, Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis, Kidney Int, 24, 626, 10.1038/ki.1983.203 Barisoni, 2000, Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies, Kidney Int, 58, 137, 10.1046/j.1523-1755.2000.00149.x Nagata, 2000, Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis, Lab Invest, 80, 869, 10.1038/labinvest.3780091 Wang, 2004, Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis, Am J Kidney Dis, 43, 19, 10.1053/j.ajkd.2003.09.010 Baker, 1994, Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis, J Clin Invest, 94, 2105, 10.1172/JCI117565 Shimizu, 1996, Apoptosis in progressive crescentic glomerulonephritis, Lab Invest, 74, 941 Thomas, 1998, Cellular apoptosis and proliferation in experimental renal fibrosis, Nephrol Dial Transplant, 13, 2216, 10.1093/ndt/13.9.2216 Tashiro, 1998, Detection of apoptotic cells in glomeruli of patients with IgA nephropathy, Nephron, 79, 21, 10.1159/000044986 Sugiyama, 1996, Apoptosis in glomerular sclerosis, Kidney Int, 49, 103, 10.1038/ki.1996.14 Haas, 1999, Regulatory mechanism in glomerular mesangial cell proliferation, J Nephrol, 12, 405 Maeshima, 1996, Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation, J Am Soc Nephrol, 7, 2219, 10.1681/ASN.V7102219 Pesce, 1991, Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone, Lab Invest, 65, 601 Wolf, 1996, Angiotensin II is mitogenic for cultured rat glomerular endothelial cells, Hypertension, 27, 897, 10.1161/01.HYP.27.4.897 Orth, 1995, Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells, Exp Nephrol, 3, 23 Wolf, 2000, Cell cycle regulation in diabetic nephropathy, Kidney Int, 77, S59, 10.1046/j.1523-1755.2000.07710.x